Tag: thrombosis

AHA Guidance on Blood Clots Linked to COVID-19 Vaccine

A newly released report is offering guidance concerning rare conditions associated with COVID-19 as well as vaccines against the virus. The report was released today...

End Pause of J&J Vaccine, but Add Warning

Editor’s note: The FDA and CDC lifted the pause on the Johnson & Johnson vaccine on Friday evening, within hours of ACIP’s decision. Use of the...

How to Counsel Worried Patients About the J&J Vaccine News

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Dr Jan E. Patterson On April 13, the CDC and the...

New Side Effects With AstraZeneca and Janssen COVID-19 Vaccines?

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. In addition to the unusual blood clots linked to the AstraZeneca...

Parity Whether Anticoagulation Is Halted or Not for Unplanned Cath

Maintaining oral anticoagulation (OAC) throughout an unplanned cardiac catheterization confers no extra risk and might hold some advantages over periprocedural OAC interruption in patients on...

UK Regulators to Offer Under-30s Alternative to AZ COVID Vaccine

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Adults under 30 years of age will be offered an alternative...

EMA Launches Review of Clot Risk With AstraZeneca COVID Vaccine

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency...

NETs a Possible Therapeutic Target for COVID-19 Thrombosis?

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Researchers in Madrid may have found a clue to the pathogenesis...

Rivaroxaban Rivals Warfarin in AF, Mitral Bioprosthesis

The direct oral anticoagulants (DOACs) took cardiology by storm a decade ago when trials showed they were at least as safe and effective as warfarin...

Clopidogrel Bests Ticagrelor for Elective PCI

Ticagrelor failed to unseat clopidogrel as the guideline-recommended P2Y12 inhibitor of choice in patients undergoing elective percutaneous coronary intervention for stable CAD in the randomized...

Thromboembolic Events High Despite Prophylaxis

Major thromboembolic complications and adverse cardiovascular events occurred with high frequency in patients with COVID-19, especially in the intensive care setting, despite a high use...

COVID-19 ICU Patients Have High Risk of Clots

By Alan Mozes HealthDay Reporter TUESDAY, Oct. 6, 2020 (HealthDay News) — Hospitalized COVID-19 patients face an increased risk of developing dangerous blood clots,...

No Migraine ‘Rebound’ Stopping Clopidogrel After ASD Closure

Patients being treated with dual-antiplatelet therapy (DAPT) consisting of clopidogrel plus aspirin following atrial septal defect (ASD) closure can safely discontinue clopidogrel after 3 months...

Mini-Dose Edoxaban May Safely Cut AF Stroke Risk in Very Elderly

An ultra-low dose of direct oral anticoagulant (DOAC) may safely cut the risk for stroke in very elderly patients with atrial fibrillation (AF) whose bleeding...

New Data on Benefit, Risk for Anticoagulation in COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Two studies from New York City, the early epicenter of the...

Aspirin Alone Preferred Antithrombotic Strategy After TAVI

Aspirin alone after transcatheter aortic valve implantation (TAVI) significantly reduced bleeding compared with aspirin plus clopidogrel, without increasing thromboembolic events, in the latest results from...

All NSAIDs Raise Post-MI Risk but Some Are Safer: Next Chapter

Patients on antithrombotics after an acute myocardial infarction (MI) will face a greater risk for bleeding and secondary cardiovascular (CV) events if they start taking...

Pre-TAVR Double BASILICA Can Spell Double Trouble

New registry data highlight the ability of the BASILICA technique to reduce coronary obstruction after transcatheter aortic valve replacement (TAVR) but also raise concerns when...

Autopsy Data Show Extensive Lung Damage From COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A detailed histologic study of lungs obtained at autopsy from patients...

Inflammation, Thrombosis Biomarkers Tied to COVID-19 Deaths

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Biomarkers for inflammation and thrombosis may predict deaths from COVID-19 among...

Evidence Builds Linking Anticoagulation to COVID-19 Survival

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Use of systemic anticoagulation may improve the chance of survival in...

Finding the Right Balance in COVID-19 Thromboprophylaxis

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. News this week that Broadway star Nick Cordera had one of...

Clopidogrel Adds No Benefit to Rivaroxaban+Aspirin

The VOYAGER PAD results from more than 6,500 patients created the biggest evidence base by far ever collected from patients with symptomatic peripheral artery disease...